Catalio, Tressa C.

HRN: 28-38-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/04/2026
02/11/2026
IV
500
Q8
S/P LTCS
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: